Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
04/2012
04/12/2012WO2012046727A1 Method for producing virus vector
04/12/2012WO2012045473A1 Viruses for the treatment of fibrosis
04/12/2012WO2012045286A1 Recombinant vector and fibroin membrane modified by transgenic bone stromal cell, and application thereof
04/12/2012US20120088228 Methods of producing high titer, high purity virus stocks and methods of use thereof
04/12/2012US20120087936 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
04/12/2012US20120087924 Recombinant B. pseudomallei Adhesin Protein and Methods and Uses Thereof
04/12/2012US20120087917 Lox and loxl2 inhibitors and uses thereof
04/12/2012CA2813675A1 Hepatitis c virus gene
04/12/2012CA2813078A1 Hemagglutinin polypeptides, and reagents and methods relating thereto
04/11/2012EP1235912B1 Tumour-specific vector for gene therapy
04/11/2012EP1071804B1 Use of triplex structure dna sequences for transferring nucleotide sequences
04/11/2012CN202187004U Full automatic inactivation system for virus harvest liquid
04/11/2012CN102414313A 多基因载体编码的重组病毒样颗粒 Multigene vectors encoding recombinant virus-like particle
04/11/2012CN102408483A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
04/11/2012CN102406927A Method for producing human diploid cell encephalitis B inactivated vaccine
04/11/2012CN102406926A 一种聚酯类纤维载体培养细胞以制备病毒或生产疫苗的方法 A method of polyester fiber carrier cultured cells to produce virus or vaccine production
04/11/2012CN101343640B 共表达CTLA4Ig和CTLA4的重组腺病毒载体、重组腺病毒及其应用 Co-expression of CTLA4Ig and CTLA4 recombinant adenovirus vector, recombinant adenovirus and its applications
04/11/2012CN101037673B 烟草病毒病砂纸摩擦接种法 Tobacco virus inoculation rubbing sandpaper
04/10/2012US8153138 Recombinant MVA virus
04/10/2012CA2486282C Virus-like particles, methods of preparation, and immunogenic compositions
04/05/2012WO2012041423A1 Method for separating off viruses from a liquid medium containing contaminants
04/05/2012WO2012041311A1 Permanent human amniocyte cell lines for producing influenza viruses
04/05/2012WO2011116226A3 Display of antibody fragments on virus-like particles of rna bacteriophages
04/05/2012US20120083412 Composition and Method for Delivery of Substances in a Dry Mode Having a Surface Layer
04/05/2012US20120082696 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/05/2012US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
04/05/2012CA2808453A1 Permanent human cell lines for the production of influenza viruses
04/04/2012EP2435572A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
04/04/2012EP2435559A1 Simian adenovirus 41 and uses thereof
04/04/2012EP2435066A1 Assays for influenza virus hemagglutinins
04/04/2012EP1942182B1 Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines
04/04/2012EP1791556B1 Modified hiv-1 envelope proteins
04/04/2012EP1774049B1 Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
04/04/2012CN1228119B Immortalized cell lines for virus growth
04/04/2012CN102399777A Recombinant plasmid and recombinant oncolytic virus prepared by using the same
04/04/2012CN102399757A Immunogenic compositions and uses thereof
04/04/2012CN102399756A Chicken Marek's disease virus (MDV) miRNA (micro Ribonucleic Acid) deletion vaccine strain and application thereof
04/04/2012CN102399755A Pig pseudorabies virus natural low-virulent C strain and heatproof preservation method thereof
04/04/2012CN102399754A H9N2 avian influenza virus vaccine strain and application of H9N2 avian influenza virus vaccine strain in immune protection
04/04/2012CN102399271A 控制种子和器官大小的蛋白及其编码基因与应用 Seed and organ size control protein and its encoding gene and application
04/04/2012CN102397539A 鸭黄病毒病灭活疫苗及其制备方法 Duck flavivirus disease vaccine and its preparation method
04/04/2012CN102397538A 亚甲蓝光化学病毒灭活方法制备的病毒疫苗的应用 Application of methylene blue photochemical viral inactivation process for the preparation of viral vaccines
04/03/2012US8148509 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
04/03/2012US8148131 Bacteriophage and antibacterial composition comprising the same
04/03/2012US8148130 Liposome carriers for use in enhancing vaccine development
04/03/2012US8148129 controlling transcription of genes, by expressing in a cell a nucleic acid construct comprising a first nucleotide sequence encoding a transcription factor protein or fragments, linked to a second nucleotide sequence encoding a protein or fragment that localizes to the transcription machinery
04/03/2012US8148060 Recombinant viral vector for gene transfer into lymphoid cells
04/03/2012US8147845 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
04/03/2012US8147822 Oncolytic virus
04/03/2012CA2586153C Mutant porcine reproductive and respiratory syndrome virus
04/03/2012CA2453115C Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
04/03/2012CA2424789C Multiple inducible gene regulation system
04/03/2012CA2379220C Structural protein of adeno-associated virus with modified antigenicity, its production and its use
04/03/2012CA2347411C Virus-like particles for the induction of autoantibodies
04/03/2012CA2302545C In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps)
04/03/2012CA2198461C Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (prrsv), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a prrsv and a method of detecting a prrsv
03/2012
03/29/2012WO2012039607A1 Methods to produce bunyavirus replicon particles
03/29/2012WO2012038454A1 Bvdv vaccine
03/29/2012WO2012037723A1 Attenuate live vaccine of vsocs gene-deleted megalocytivirus, method to prepare the same and use thereof
03/29/2012WO2011130119A3 Methods of producing high titer, high purity virus stocks and methods of use thereof
03/29/2012US20120078093 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
03/29/2012US20120077249 Separation Of Virus And/Or Protein From Nucleic Acids By Primary Amines
03/29/2012US20120077248 Method for determining crystallization parameters and apparatus for use with the same
03/29/2012US20120076821 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
03/29/2012US20120076820 Cd40l vaccines, compositions, and methods related thereto
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012CA2812096A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012CA2812058A1 Dissociation of product-complexed contaminants in chromatography
03/29/2012CA2811243A1 Bvdv vaccine
03/28/2012EP2434012A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
03/28/2012EP2432885A2 Methods for enhancing infectivity of retroviruses
03/28/2012CN102392039A HIV-1B subtype drug-resistant mutant and construction method and application thereof
03/28/2012CN102391996A Recombination VTT and method for detecting vaccinia virus neutralizing antibody by using same
03/27/2012US8143213 Effect of TULA on HIV
03/27/2012US8143022 High production system for infectious hepatitis C virus particle
03/27/2012US8142796 Monoparamunity inducers based on attenuated rabbit myxomaviruses
03/27/2012US8142795 Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
03/27/2012US8142794 Hepatitis C virus vaccine
03/27/2012US8142770 Drug comprising as the active ingredient proliferative vector containing survivin promoter
03/27/2012CA2378497C Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
03/27/2012CA2230029C Multi-subtype fiv vaccines
03/22/2012WO2005032457A3 Vectors and methods for immunization against norwalk virus using transgenic plants
03/22/2012CA2811472A1 Antibacterial phage, phage peptides and methods of use thereof
03/21/2012EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells
03/21/2012EP2431468A1 Interleukin-1 conjugates and uses thereof
03/21/2012EP2429580A1 Method for orthopoxvirus production and purification
03/21/2012EP2429579A1 Immortalized avian cell lines and use thereof
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012EP1088077B2 Newcastle disease virus infectious clones, vaccines and diagnostic assays
03/21/2012CN1554764B Recombinant mva virus, and the use thereof
03/21/2012CN102382812A Reverse genetics operating system of infectious bronchitis virus H120 vaccine strain and operating method thereof
03/21/2012CN102382803A Construction method of novel gene engineering recombinant virus for expressing gp64 gene
03/21/2012CN102380093A Method for producing newcastle disease living vaccines by utilizing passage fibroblasts
03/21/2012CN101555469B High-efficiency recombined adenovirus containing ndrg2 gene and pharmic purpose thereof
03/21/2012CN101463345B Virus propagation promotor and use thereof
03/21/2012CN101355963B Marked bovine viral diarrhea virus vaccines
03/21/2012CN101048502B Modified human hepatitis c virus genomic RNA having autonomous replicative competence
03/20/2012US8138390 Biological control agent for plants
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 267